Our latest article “Classification of Medical Devices and Placing the Same on the Market” by Nihan Bacanak, Zeynep Toma and Selen Toma is published on Mondaq.
Medical Device Regulation (the “MDR“) and In Vitro Diagnostic Medical Device Regulation (the “IVDR“), as adopted by the Turkish Medicine and Medical Devices Authority (“Authority“) are the main pieces of legislation in Turkey in relation to medical devices. With an effort to align with the EU standards, the provisions of MDR and IVDR mostly mirror the provisions of Medical Devices Regulation numbered 2017/475 and In Vitro Diagnostic Medical Devices Regulation numbered 2017/746 of the European Union.
Medical devices are classified in two main categories under the Turkish medical devices legislation: (i) medical devices and (ii) in vitro diagnostic medical devices. There are a number of sub-categories under the MDR such as invasive, non-invasive, custom-made, active, investigational, implantable medical devices. Certain products that may be considered as non-medical per se such as contact lenses, cosmetic implant devices, liposuction equipment, lasers and brain stimulation equipment are also included within the scope of the MDR, and are thus subject to the related medical devices legislation.
Classification. Medical devices are classified on a risk-basis approach under (i) Classes I, IIa, IIb and III for medical devices, and (ii) A, B, C and D for in vitro diagnostic medical devices from the lowest to the highest risk group. The risk classes are determined based on the intended usage purpose of the medical device and the risks that the medical device entails due to its nature and complexity.
You may reach the full of article here.
Share
Related persons
You can contact us for detailed information.



Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
10 September 2026
The Turkish Competition Authority releases a leading food delivery platform from most of its binding commitments following the loss of its dominance, but keeps the narrow price parity commitment in place for two more years
This article examines the Turkish Competition Board’s Yemek Sepeti Decision, assessing a request for the removal of commitments made…
9 September 2026
Türkiye’s defence sector: investment climate, legal framework and strategic outlook
Türkiye’s defence industry has undergone a notable transformation in recent years, both in terms of production capabilities and…
2 September 2026
The ACFE Report to the Nations 2026: key considerations for general counsel and compliance officers in Türkiye
Occupational fraud rarely remains a purely financial issue. It can quickly become a board-level governance concern, create regulatory…
1 September 2026
More power, less protection: job security exclusions for employer representatives
The Turkish Labour Code establishes a comprehensive job security framework that shields employees from unjustified dismissal. It does,…
31 August 2026
Significant CMB principle decisions on block trades and IPOs
On 27, 28 and 31 August 2026, the Capital Markets Board of Türkiye issued principle decisions introducing significant changes to the rules…
25 August 2026
Turkish competition law newsletter – Issue 2026/3
Turkish competition enforcement has entered a phase in which the Turkish Competition Authority’s most consequential interventions…